Tsoi, H.; Shi, L.; Leung, M.-H.; Man, E.P.S.; So, Z.-Q.; Chan, W.-L.; Khoo, U.-S.
Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. Life 2024, 14, 1044.
https://doi.org/10.3390/life14081044
AMA Style
Tsoi H, Shi L, Leung M-H, Man EPS, So Z-Q, Chan W-L, Khoo U-S.
Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. Life. 2024; 14(8):1044.
https://doi.org/10.3390/life14081044
Chicago/Turabian Style
Tsoi, Ho, Ling Shi, Man-Hong Leung, Ellen P. S. Man, Zi-Qing So, Wing-Lok Chan, and Ui-Soon Khoo.
2024. "Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93" Life 14, no. 8: 1044.
https://doi.org/10.3390/life14081044
APA Style
Tsoi, H., Shi, L., Leung, M.-H., Man, E. P. S., So, Z.-Q., Chan, W.-L., & Khoo, U.-S.
(2024). Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. Life, 14(8), 1044.
https://doi.org/10.3390/life14081044
